Recent experimental evidence has focused attention to the role of two molecules, insulin receptor substrate 1 (IRS-1) and phosphatidylinositol 3-kinase (PI3-kinase), in linking the insulin receptor to glucose uptake; IRS-1 knockout mice are insulin resistant, and pharmacological inhibitors of P13-kinase block insulin-stimulated glucose uptake. To investigate the role of P13-kinase and IRS-i in insulin-stimulated glucose uptake we examined whether stimulation of insulin-sensitive cells with platelet-derived growth factor (PDGF) or with interleukin 4 (IL-4) stimulates glucose uptake; the activated PDGF receptor (PDGFR) directly binds and activates P13-kinase, whereas the IL-4 receptor (IL-4R) activates P13-kinase via IRS-1 or the IRS-1-related molecule 4PS. We found that stimulation of 3T3-L1 adipocytes with PDGF resulted in tyrosine phosphorylation of the PDGFR and activation of P13-kinase in these cells. To examine whether IL-4 stimulates glucose uptake, L6 myoblasts were engineered to overexpress GLUT4 as well as both chains of the IL-4R (L6/IL-4R/GLUT4); when these L6/IL-4R/GLUT4 myoblasts were stimulated with IL-4, IRS-1 became tyrosine phosphorylated and associated with PI3-kinase. Although PDGF and IL-4 can activate P13-kinase in the respective cell lines, they do not possess insulin's ability to stimulate glucose uptake and GLUT4 translocation to the plasma membrane. These findings indicate that activation of P13-kinase is not sufficient to stimulate GLUT4 translocation to the plasma membrane. We postulate that activation of a second signaling pathway by insulin, distinct from PI3-kinase, is necessary for the stimulation of glucose uptake in insulin-sensitive cells.
One of the major physiological functions of insulin is to maintain blood glucose homeostasis. Binding of insulin to its receptor on fat cells and skeletal muscle induces the uptake of glucose from blood by stimulating the redistribution of the glucose transporter, GLUT4, from an intracellular compartment to the plasma membrane (1, 2) . Although it is well established that insulin stimulates GLUT4 translocation by interacting with a transmembrane receptor that possesses tyrosine kinase activity (3) , the intracellular signals that link the insulin receptor to glucose uptake are less well understood.
A critical early event that is necessary for insulin to stimulate glucose uptake and occurs following ligand binding is activation of the receptor tyrosine kinase domain (4) ; this results in receptor autophosphorylation and tyrosine phosphorylation of several intermediate proteins including insulin receptor substrate 1 (IRS-1) (5) . Tyrosine phosphorylated IRS-1 then couples the insulin receptor to downstream signaling pathways by serving as a docking protein for signaling molecules with src homology (SH) 2 and SH3 domains (5) (6) (7) (8) . IRS-1 has been shown to be important in coupling the insulin receptor to biological responses such as mitogenesis and glucose uptake (5, (9) (10) (11) . For example, reintroduction of IRS-1 into the 32D cells lacking IRS-1 and the IRS-1-related molecule, 4PS, restores insulin-stimulated mitogenesis in this cell line (11) . In addition, IRS-1 knockout mice exhibit insulin resistance, indicating that IRS-1 is important for mediating metabolic responses by the insulin receptor (9, 10) .
Phosphatidylinositol 3-kinase (PI3-kinase), which is responsible for phosphorylating phosphatidylinositol (PI), PI-4-P, and PI-4,5-P2, is one of the signaling molecules that is activated by binding IRS-1 and has been implicated in linking the insulin receptor to glucose transport (12, 13) . P13-kinase is a heterodimer consisting of an 85-kDa protein (p85) tightly associated with a 110-kDa catalytic subunit (p110) (14, 15) . p85 contains two SH2 domains and functions as a regulatory subunit for the P13-kinase molecule (15, 16) ; binding of the SH2 domains of p85 to tyrosine phosphorylated IRS-1 in insulin-stimulated cells induces a conformational change leading to activation of the pllO catalytic subunit (7). Thus far, three related p85 molecules and two pllO family members, pllOa and p110, have been cloned from mammalian cells (15) (16) (17) (18) .
The exact function of P13-kinase in mammalian cells is not known, although several studies in yeast and mammalian cells have suggested that P13-kinase may be important in mediating various cellular responses to growth factors, including mitogenesis, Ras activation, p70 S6 kinase activation, and membrane trafficking (12, (19) (20) (21) . With respect to membrane trafficking, VPS34 is a yeast protein involved in targeting proteins to vacuoles and in vacuole morphogenesis; it has sequence homology to the C-terminal catalytic domain of mammalian pllOa and p11083 and functions as a P13-kinase in yeast (22) . These data led to the initial hypothesis that mammalian P13-kinase may also be important in vesicular targeting of proteins or vesicular transport in mammalian cells, and this further suggested a role for P13-kinase in insulininduced translocation of GLUT4 to the plasma membrane. In support of this suggestion, the P13-kinase inhibitors wortmannin and LY294002 have been shown to inhibit GLUT4 translocation to the plasma membrane and glucose transport in insulin-stimulated 3T3-L1 adipocytes (12, 13) .
To further investigate the role of P13-kinase in insulinstimulated glucose transport, we examined whether activation of PI3-kinase by receptors other than the insulin receptor would stimulate GLUT4 translocation to the plasma membrane and glucose uptake in insulin-sensitive cell lines. We reasoned that if activation of P13-kinase was sufficient to stimulate GLUT4 translocation, other receptors 4To whom reprint requests should be addressed.
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ulate glucose uptake and GLUT4 translocation. We report here that activation of PI3-kinase via IRS-1 using the interleukin 4 receptor (IL-4R) in L6 myoblasts, or via the plateletderived growth factor receptor (PDGFR) in 3T3-L1 adipocytes, does not mimic insulin's ability to stimulate glucose uptake and GLUT4 translocation. Accordingly, we postulate that activation by insulin of a second signaling pathway, distinct from the P13-kinase pathway, is necessary for stimulation by insulin of glucose uptake in insulin-sensitive cells.
MATERIALS AND METHODS
Cell Lines and Growth Factors. Two days after reaching confluence, murine 3T3-L1 fibroblasts were differentiated into adipocytes as described (12) . Experiments on adipocytes were performed between 10 and 20 days after differentiation. L6/IL-4R cells are L6 rat myoblasts stably transfected with the IL-4Ra and IL-2Ry chains (23) . To overexpress GLUT4, the rat GLUT4 cDNA was subcloned into the retroviral vector LXSHD (kindly provided by Dusty Miller) (24) and GLUT4-containing retroviruses were used to infect L6/IL-4R myoblasts. Histidinol-resistant clones were isolated and GLUT4 overexpression was determined by Western blotting.
Antibodies, Immunoprecipitation, and Immunoblotting. GLUT4 antibodies were raised against the C-terminal 16 amino acids of rat GLUT4 (24) (kindly provided by M. Mueckler, Washington University, St. Louis). GLUT1 antibodies were purchased from East Acres Biologicals (Southbridge, MA). Antibodies to p85, IRS-1, and phosphotyrosine are rabbit polyclonal antibodies (6) . Cell lysis, immunoprecipitation, and immunoblotting were performed as described (6) .
Glucose Uptake. Glucose uptake was assayed using 2-deoxy- (26) . After overnight serum starvation, adipocytes were stimulated for 20 min with insulin or PDGF and subjected to the fractionation protocol. Plasma membrane lawns were prepared from L6/IL-4R/GLUT4 myoblasts (L6 myoblasts engineered to overexpress the IL-4Ra and IL-2R-y chains and GLUT4) plated onto coverslips as described (27) with the exception that lawns were permeabilized with 0.2% Triton X-100 after fixation. Plasma membrane lawns were detected by immunofluorescence with wheat germ agglutinin coupled to Texas red, and GLUT4 present in the plasma membrane was detected by immunofluorescence using an antibody to GLUT4 and a secondary anti-rabbit IgG antibody coupled to fluorescein isothiocyanate.
P13-Kinase Assay. PI3-kinase assays were performed as described by Whitman et al. (28) .
RESULTS
PDGF and Insulin, But Not Epidermal Growth Factor (EGF), Activate P13-Kinase in 3T3-L1 Adipocytes. To determine whether activation of P13-kinase by receptor tyrosine kinases other than the insulin and insulin-like growth factor I receptors can stimulate glucose uptake and GLUT4 translocation to the plasma membrane in insulin-sensitive cells, we examined whether 3T3-L1 adipocytes contain PDGFRs and whether PDGF activates P13-kinase in these cells. We found that 3T3-L1 adipocytes contained PDGFRs and that, in response to PDGF stimulation, the PDGFR was tyrosine phosphorylated and activated P13-kinase (Fig. 1 ). p85a and P13-kinase activity coimmunoprecipitated with antibodies to phosphotyrosine in 3T3-L1 adipocytes stimulated with PDGF or insulin but not in control unstimulated cells (Fig. 1) . EGF, which has been shown previously not to stimulate glucose uptake or the translocation of GLUT4 to the plasma membrane in 3T3-L1 adipocytes (29) , does not activate PI3-kinase in these cells (Fig. 1) .
Glucose Uptake in 3T3-L1 Adipocytes Stimulated with Insulin and PDGF. The finding that PDGF activates P13-kinase in 3T3-L1 adipocytes led us to test whether PDGF functions similarly to insulin to stimulate glucose uptake in these cells. In agreement with previous findings, EGF, which does not activate P13-kinase, did not stimulate glucose uptake in 3T3-L1 adipocytes (Fig. 2) . Insulin stimulated a 5-fold increase in glucose uptake over control cells. However, stimulation with 50 ng of PDGF per ml led to only a 1.5-fold increase in glucose uptake (Fig. 2) . A dose-response curve demonstrated that PDGF induced maximal glucose uptake at a concentration of 50 ng/ml (data not shown). These findings indicate that activation of P13-kinase in itself is not a sufficient condition for induction of maximal increases in glucose uptake in 3T3-L1 adipocytes. Although PDGF is a better activator of P13-kinase in 3T3-L1 adipocytes than insulin, it stimulates a much smaller increase in glucose uptake in these cells.
PDGF Does Not Induce the Translocation of GLUT4 to the Plasma Membrane in 3T3-L1 Adipocytes. Insulin stimulates glucose uptake in adipocytes by increasing the translocation of GLUT4 to the plasma membrane and by increasing the intrinsic function of the GLUT4 transporter (1, 2) . To investigate how PDGF mediates the small increase in glucose uptake in 3T3-L1 adipocytes, we determined the cellular localization of GLUT4 and GLUT1 in 3T3-L1 adipocytes stimulated with PDGF or insulin. GLUT1 has a wide tissue distribution and, in contrast to GLUT4, is present predominantly at the cell surface (1, 2). Plasma membrane and crude microsomal fractions isolated from adipocytes stimulated with insulin or PDGF were separated by SDS/PAGE (10%) and immunoblotted with antibodies to GLUT4 or GLUT1. Stimulation of 3T3-L1 adipocytes with PDGF or insulin increased GLUT1 in the plasma membrane and decreased it in the microsomal pool (Fig. 3B) . However, only insulin stimulation increased GLUT4 in the plasma membrane fraction (Fig. 3A) . Thus, in contrast to insulin, which induced the translocation of GLUT1 and GLUT4 to the plasma membrane (Fig. 3) , PDGF induced the translocation of only GLUT1.
Activation of PI3-Kinase via IRS-1 by the IL-4R Does Not Stimulate Glucose Uptake in L6 Myoblasts. The above results with PDGF do not rule out the possibility that P13-kinase activation is a sufficient requirement for the stimulation by insulin of glucose uptake and GLUT4 translocation to the plasma membrane. Whereas the PDGFR directly binds and activates PI3-kinase, the insulin receptor indirectly activates PI3-kinase by tyrosine phosphorylating IRS-1, which then binds and activates P13-kinase (7, 30) . Thus, the failure of PDGF to stimulate tyrosine phosphorylation of IRS-1 may be one explanation for the inability of PDGF to stimulate glucose transport.
To determine whether activation of P13-kinase via IRS-1 is sufficient to stimulate glucose uptake and GLUT4 translocation, we used an L6 myoblast cell line that was Fig. 4B ). The IL-4R has previously been shown to tyrosine phosphorylate IRS-1 (5, 11, 23) . We chose L6 myoblasts, rather than 3T3-L1 adipocytes, because the latter lack the Janus tyrosine kinase 3, which is required for IRS-1 phosphorylation by the IL-4R (31). We found that in L6/IL-4R/GLUT4 cells, IRS-1 was tyrosine phosphorylated in response to stimulation with either IL-4 or insulin and that it associated with P13-kinase to a similar degree in both cases ( Fig. 4A; ref. 23 ; data not shown).
However, although stimulation with insulin and IL-4 led to similar levels of P13-kinase activation in L6 myoblasts, only insulin stimulated glucose uptake and GLUT4 translocation. Stimulation of L6/IL-4R/GLUT4 with insulin resulted in a 2-to 3-fold increase in glucose uptake, while stimulation with IL-4 led to only a 1.1-to 1.2-fold increase in glucose uptake (Fig. 5 ). In addition, unlike insulin, IL-4 did not induce the translocation of GLUT4 to the plasma membrane; an increase in GLUT4 was detected in plasma membrane lawns from L6/IL-4R/GLUT4 cells stimulated with insulin but not in cells stimulated with IL-4 (Fig. 6 ). These findings demonstrate that activation of P13-kinase via IRS-1 is, in itself, also not sufficient to stimulate GLUT4 translocation to the plasma membrane in insulin-sensitive L6 myoblasts.
DISCUSSION
Our results demonstrate that activation of P13-kinase is not sufficient to stimulate glucose uptake in insulin-sensitive cells. We found that PDGF and IL-4 can activate PI3-kinase in 3T3-L1 adipocytes and L6 myoblasts, respectively; however, these factors did not increase glucose uptake to an extent comparable to that induced by insulin. Moreover, while insulin stimulated the translocation of GLUT4 to the plasma membrane in both cell lines, neither PDGF nor IL-4 elicited this translocation.
One of the difficulties in studying regulation of glucose transport and GLUT4 translocation is the lack of favorable experimental model systems. Only fat and muscle cells express endogenous GLUT4 and are insulin-sensitive; insulin stimulation leads to a rapid increase in glucose transport that is mediated by the translocation of GLUT4 to the plasma membrane (1) . We used two cell lines, 3T3-L1 adipocytes and L6 myoblasts, that are considered good model systems (2, 25, 27) ; the results, most likely, are representative of glucose transport regulation in vivo in fat and muscle cells.
One interpretation of our data may be that activation of P13-kinase by insulin is qualitatively different than activation of P13-kinase by either PDGF or IL-4. However, we think this is unlikely to explain our results. First, a previous study has shown that activated P13-kinase is found in the same intracellular location as tyrosine-phosphorylated IRS-1 in insulinstimulated cells (32) . Therefore, if the subcellular localization of activated P13-kinase is critical for P13-kinase to stimulate GLUT4 translocation (33) (35, 36) . The conclusion in ref. 35 that PDGF induces GLUT4 translocation in 3T3-L1 adipocytes was based on the cellular localization of an epitopetagged GLUT4 transporter rather than on the localization of the endogenous GLUT4 transporter as reported in the present study. It is possible that epitope-tagged GLUT4 transfected into 3T3-L1 adipocytes is regulated differently than the endogenous GLUT4 or that overexpression of GLUT4 to very high levels in 3T3-L1 adipocytes allows PDGF to induce the translocation of a small fraction of GLUT4 through pathways that are normally not utilized by insulin to regulate translocation of the endogenous GLUT4 transporter.
It is important to point out that conclusive evidence linking PI3-kinase to insulin-stimulated translocation of GLUT4 to the plasma membrane in insulin-sensitive cells does not yet exist. Most studies linking glucose uptake to P13-kinase in mammalian cells have relied on the use of two pharmacological inhibitors of PI3-kinase, wortmannin, and LY294002 (12, 13) . Though these compounds appear to be specific for P13-kinase at low concentrations, it may be premature to conclude that these compounds do not inhibit other molecules that are critical for glucose uptake. In addition, a growing number of P13-kinases are being identified in mammalian cells (37, 38) . At least some of these are immunologically distinct from pllOa and pllO3 and do not couple to p85 (38) . Thus, even if pharmacological inhibitors of P13-kinase turn out to be very specific, they cannot clarify which of the various P13-Proc. Natl. Acad. Sci. USA 92 (1995) 10251 kinases are actually important in mediating glucose uptake. Moreover, the recent demonstration that mammalian cells contain P13-kinases that only phosphorylate PI and may be more homologous to VPS34 than pllOa or pllO (which predominantly phosphorylates PI-4,5-P2 in vivo) suggests that the functions attributable to VPS34 may not apply to other P13-kinase family members (37, 38, 41) .
Although the results reported here do not rule out a possible role for PI3-kinase in insulin-mediated glucose uptake, they provide evidence that at least one additional signaling pathway is necessary for insulin function. The fact that IL-4 tyrosine phosphorylates IRS-1 without stimulating glucose uptake raises the possibility that an IRS-1-independent signal(s), in addition to an IRS-1-dependent signal(s), is critical for stimulation by insulin of glucose uptake. The nature of this postulated second signal is still not known, although previous studies have ruled out involvement of the p2lRas/Map kinase and p70 S6 kinase pathways in glucose uptake by insulin (29, 34, 39, 40) . Further studies are needed to determine conclusively whether the p85--pllO heterodimeric P13-kinase activated by binding IRS-1 in insulin-stimulated cells is necessary for insulin stimulation of GLUT4 translocation to the plasma membrane. In addition, the mechanism whereby PI3-kinase functions to stimulate glucose uptake needs to be determined. The studies reported here indicate that even if P13-kinase is shown to be important in mediating insulin's effect, additional signaling pathways for insulin-mediated glucose uptake await identification.
